PRESS RELEASE published on 11/22/2023 at 22:30, 2 years 9 months ago LQR House Addresses Nasdaq Delisting Determination with Formal Appeal Measures
PRESS RELEASE published on 11/22/2023 at 14:50, 2 years 9 months ago LQR House Partners with Kylix for Viral Content Campaign, Amplifying E-commerce Sales and Entering the $4.67 Billion Global Hangover Cure Market
PRESS RELEASE published on 11/21/2023 at 16:05, 2 years 9 months ago LQR Announces Proposed Reverse Split as Part of Nasdaq Compliance Plan
PRESS RELEASE published on 11/20/2023 at 22:45, 2 years 9 months ago LQR House Repurchases 1,476,355 Shares in Ongoing Share Buy Back Initiative
PRESS RELEASE published on 11/13/2023 at 22:05, 2 years 9 months ago LQR House Inc. Announces Closing of $11 Million Public Offering
PRESS RELEASE published on 11/13/2023 at 13:30, 2 years 9 months ago LQR House Inc. and Cabal Tequila Partner for Dynamic Marketing and Awareness Campaign, Paving the way for COSTCO Shelf Placement in California via Alpha Distro Partnership
PRESS RELEASE published on 11/10/2023 at 14:00, 2 years 10 months ago LQR House Inc. Announces Pricing of $11 Million Public Offering
PRESS RELEASE published on 11/01/2023 at 13:30, 2 years 10 months ago LQR House Strengthens Its Position by Acquiring Alcohol E-Commerce Platform, Enabling Direct Sales to Consumers
PRESS RELEASE published on 10/24/2023 at 14:30, 2 years 10 months ago LQR House Partners with Nuke Waste Spirits for Holiday Promotion Featuring Influencer-Generated Content and Bright Green Melon Flavored Vodka
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 10 months ago LQR House Forms Strategic Alliance With Beväge(R), Poised to Revolutionize E-commerce and Direct-to-Consumer Channels
Published on 09/10/2026 at 22:25, 14 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 21 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 22 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 1 hour 17 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 1 hour 25 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 1 hour 30 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 45 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 17 hours 30 minutes ago Availability of the 2026 Interim Financial Report
